HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.

AbstractBACKGROUND:
Lipid oxidation of membrane phospholipids is accompanied by the formation of oxidation-specific epitopes (OSE). These epitopes are recognized by specific antibodies and represent danger-associated molecular patterns that are generated during chronic inflammatory processes. In a murine model for hepatic inflammation during non-alcoholic fatty liver disease (NAFLD), increased antibody levels targeting OSE were found to be protective. Here, our aim was to determine an association between OSE-specific antibody titers and NAFLD in humans.
METHODS:
IgM and IgG levels with specificity for various OSE were assessed in the plasma of patients with NAFLD (n = 71) and healthy controls (n = 68). Antibody titers were comprehensively analyzed in patients with NAFLD after classification by histological evaluation of liver biopsies. Statistical analysis was performed to determine significant correlations and odds ratios. To study the specificity for NAFLD, plasma antibody titers were measured in patients with hepatitis C (n = 40) and inflammatory bowel disease (n = 62).
RESULTS:
IgM titers against OSE were lower in patients with NAFLD compared to controls. Further biopsy-based classification of patients with NAFLD did not show any difference in IgM levels. Plasma IgM titers towards the P1 mimotope demonstrated an inverse correlation with markers for obesity, systemic inflammation, and liver damage. In contrast, hepatitis C and increased disease activity during inflammatory bowel disease was not associated with reduced IgM titers.
CONCLUSIONS:
Our data highlight the importance of immune recognition of OSE by IgM antibodies in the pathophysiology of NAFLD.
AuthorsTim Hendrikx, Martin L Watzenböck, Sofie M A Walenbergh, Shahzada Amir, Sabrina Gruber, Maria Ozsvar Kozma, Heike I Grabsch, Ger H Koek, Marieke J Pierik, Katharina Staufer, Michael Trauner, Satish C Kalhan, Daisy Jonkers, Marten H Hofker, Christoph J Binder, Ronit Shiri-Sverdlov
JournalBMC medicine (BMC Med) Vol. 14 Issue 1 Pg. 107 (07 22 2016) ISSN: 1741-7015 [Electronic] England
PMID27443391 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Epitopes
  • Immunoglobulin G
  • Immunoglobulin M
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • Case-Control Studies
  • Epitopes
  • Female
  • Humans
  • Immunoglobulin G (blood)
  • Immunoglobulin M (blood)
  • Lipid Metabolism (immunology)
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease (blood, immunology)
  • Oxidation-Reduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: